Cargando…
Olodaterol exerts anti-inflammatory effects on COPD airway epithelial cells
BACKGROUND: Airway inflammation is a key feature of chronic obstructive pulmonary disease (COPD) and inhaled corticosteroids (ICS) remain the main treatment for airway inflammation. Studies have noted the increased efficacy of ICS and long-acting beta 2 agonist (LABA) combination therapy in controll...
Autores principales: | Yang, Nan, Singhera, Gurpreet K., Yan, Yi Xuan, Pieper, Michael P., Leung, Janice M., Sin, Don D., Dorscheid, Delbert R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901009/ https://www.ncbi.nlm.nih.gov/pubmed/33622325 http://dx.doi.org/10.1186/s12931-021-01659-2 |
Ejemplares similares
-
Airway Epithelial-Derived Immune Mediators in COVID-19
por: Guo, Tony J. F., et al.
Publicado: (2023) -
ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19
por: Leung, Janice M., et al.
Publicado: (2020) -
Expression of surfactant protein D in airways of asthmatics and interleukin-13 modulation of surfactant protein D in human models of airway epithelium
por: Xu, Jie, et al.
Publicado: (2015) -
IL-13Rα2/AP-1 complex signalling mediates airway epithelial repair without effects on remodeling pathways
por: Yang, Jasemine S, et al.
Publicado: (2010) -
Apoptosis of viral-infected airway epithelial cells limit viral production and is altered by corticosteroid exposure
por: Singhera, Gurpreet K, et al.
Publicado: (2006)